Key result
Decreased baroreflex sensitivity independently predicted all-cause mortality in patients with left ventricular systolic dysfunction, with an LVEF-adjusted HR of 6.52.
Why the study?
Because modern treatment of systolic dysfunction has substantially improved, it was unknown whether autonomic indices like BRS and HRV remain accurate predictors of mortality.
Do autonomic nervous system parameters (baroreflex sensitivity and heart rate variability) predict all-cause mortality in clinically stable patients with left ventricular systolic dysfunction?
Cohort (n=205)
No
Do autonomic nervous system parameters (baroreflex sensitivity and heart rate variability) predict all-cause mortality in clinically stable patients with left ventricular systolic dysfunction?
Baroreflex sensitivity and heart rate variability remain independent predictors of all-cause mortality in modern-era patients with left ventricular systolic dysfunction.
Answers are grounded in this paper and cite their sources.
May support risk stratification in LV systolic dysfunction; leaves open whether testing improves outcomes or guides therapy.
BACKGROUND: Autonomic imbalance is associated with poor prognosis of patients with systolic dysfunction. Most of the previous data were written several years ago and constituted to cardiovascular or arrhythmic mortality. The current treatment of these patients has improved substantially over the last decades, and thus, the population at risk of death may have altered as well. Consequently, data on high-risk patients with systolic dysfunction in the modern era are sparse and those from previous trials may no longer be applicable. The aim herein, was to verify whether well-known autonomic indices - baroreflex sensitivity (BRS) and heart rate variability (HRV) - remain accurate predictors of mortality in patients with systolic dysfunction. METHODS: Non-invasively obtained BRS and HRV were analyzed in 205 clinically stable patients with left ventricular ejection fraction (LVEF) ≤ 40%. 28 patients died within 28 ± 9 month follow-up. RESULTS: Baroreflex sensitivity, low-frequency (LF) in normalized units, LF to high-frequency ratio and standard deviation of average R-R intervals were significantly associated with mortality; cut-off values of the highest discriminatory power for abovementioned parameters were ≤ 3.0 ms/mmHg, ≤ 41, ≤ 0.7 and ≤ 25 ms, respectively. In bivariate Cox analyses (adjusted for LVEF, New York Heart Association [NYHA] or absence of implantable cardioverter-defibrillator [ICD]) autonomic indices remain significant predictors of death. CONCLUSIONS: Baroreflex sensitivity and HRV - may still be helpful in identifying patients with left ventricular systolic dysfunction at the highest risk of all-cause mortality, independently of LVEF, NYHA class, and ICD implantation.
No takes yet. Share an insight, caveat, or question.
Kaufmann et al. (2019) conducted a cohort in Left ventricular systolic dysfunction (n=205). Decreased baroreflex sensitivity (≤ 3.0 ms/mmHg) vs. BRS > 3.0 ms/mmHg was evaluated on All-cause mortality (HR 6.52, 95% CI 2.36-17.96, p=<0.0001). Decreased baroreflex sensitivity independently predicted all-cause mortality in patients with left ventricular systolic dysfunction, with an LVEF-adjusted HR of 6.52.
Synapse has enriched 10 related papers. Consider them for comparative context: